SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 97,600
-1,100 (-1.11%)
Mar 12, 2026, 11:10 AM KST
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 7.73 trillion as of March 11, 2026. Its market cap has decreased by -20.66% in one year.
Market Cap
7.73T
Enterprise Value
7.54T
Revenue
675.41B
Ranking
n/a
PE Ratio
24.12
Stock Price
97,600.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 7.73T, a decrease of -22.28%. That is a compound annual growth rate of -4.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 7.73T | -20.79% |
| Dec 30, 2025 | 9.76T | 12.15% |
| Dec 30, 2024 | 8.70T | 10.66% |
| Dec 28, 2023 | 7.86T | 39.25% |
| Dec 29, 2022 | 5.65T | -25.82% |
| Dec 30, 2021 | 7.61T | -42.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALTEOGEN | 19.95T |
| LigaChem Biosciences | 7.25T |
| HLB Co., Ltd. | 6.75T |
| Peptron | 6.13T |
| Voronoi | 5.93T |
| OliX Pharmaceuticals | 4.18T |
| D&D Pharmatech | 3.65T |
| PharmaResearch | 3.46T |